Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Marcus Shaker and John Oppenheimer.
Connection Strength

2.185
  1. Reply to "How important is the second dose of the COVID-19 mRNA vaccine?" J Allergy Clin Immunol Pract. 2021 06; 9(6):2537-2539.
    View in: PubMed
    Score: 0.237
  2. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract. 2021 07; 9(7):2556-2561.
    View in: PubMed
    Score: 0.235
  3. The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract. 2021 04; 9(4):1438-1441.
    View in: PubMed
    Score: 0.232
  4. Reply to "Challenges to pediatric services during COVID-19 pandemic: A London, UK perspective". J Allergy Clin Immunol Pract. 2020 09; 8(8):2835-2836.
    View in: PubMed
    Score: 0.222
  5. Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
    View in: PubMed
    Score: 0.220
  6. Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol". J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2450-2452.
    View in: PubMed
    Score: 0.220
  7. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist. J Allergy Clin Immunol Pract. 2020 06; 8(6):1781-1790.e3.
    View in: PubMed
    Score: 0.219
  8. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020 05; 8(5):1477-1488.e5.
    View in: PubMed
    Score: 0.218
  9. Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis. JAMA Netw Open. 2019 10 02; 2(10):e1913951.
    View in: PubMed
    Score: 0.211
  10. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567.
    View in: PubMed
    Score: 0.059
  11. The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19. J Allergy Clin Immunol Pract. 2020 09; 8(8):2474-2480.e1.
    View in: PubMed
    Score: 0.056
  12. A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2125-2134.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.